Drug-Eluting Stents-Market Insights, Competitive Landscape and, Market Forecast-2026 | Analytical Research Cognizance

Drug-Eluting Stents-Market Insights, Competitive Landscape and, Market Forecast-2026

Published by ARCDI001
Report ID 1667962
Published date Apr 13, 2021
Category Medical Devices
Total Pages 120
Choose license type Buy Now
Request a Sample Enquiry Before Buying Check Discount

DelveInsight’s ‘Drug-Eluting Stents - Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Drug-Eluting Stents and the historical and forecasted Drug-Eluting Stents market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.

The Drug-Eluting Stents market report provides an overview of Drug-Eluting Stents, applications of Drug-Eluting Stents as well as its PEST Analysis. Additionally, the report provides insight on the Drug-Eluting Stents market share of the individual Drug-Eluting Stents, current and forecasted Drug-Eluting Stents market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Drug-Eluting Stents Overview
Stents are small, expandable tubes inserted after percutaneous coronary intervention (PCI) to keep the arteries open and improve the blood flow. In general, stents are classified into two: bare metal stents and drug eluting stents. Earlier the drug eluting stents were made of stainless steel and were coarse. Currently, new generation drug eluting stents are in more use as they are made of different kinds of alloys, such as cobalt chromium or platinum chromium, are thinner, have high radial strength and radiopacity, and enhance biocompatibility as well as corrosion resistance.

Study Period: 2018–2026

Geography Covered
The US
EU5 (Germany, France, Spain, Italy, and the United Kingdom)
Japan

List of Companies
Abbott, Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, STENTYS SA, Lepu Medical, Cook, and Cardinal Health, among others

Drug-Eluting Stents - Competitive Analysis
This segment of the report provides a brief competitive analysis of Drug-Eluting Stents, to help understand the competition in the market. It gives a comparative understanding of the products based on type.

Drug-Eluting Stents: Market Segmentation
By Product Type
Coronary stent
Peripheral stent
By Scaffold
Cobalt-chromium alloy
Nitinol
Others
By End-User
Hospitals
Specialty Clinics

Drug-Eluting Stents: Market Dynamics
Market Drivers
Rising demand for minimally invasive procedures
Shifting preferences towards drug-eluting stents over angioplasty
Market Barriers
Risk associated with the stents

Drug-Eluting Stents: Market Analysis
This segment illustrates the market of Drug-Eluting Stents across the 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR.

KOL Views
To keep up with the market trends, we take KOLs and SME’s opinion working in Drug-Eluting Stents domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Drug-Eluting Stents market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report
The report covers the descriptive overview of Drug-Eluting Stents, explaining its applications, advantages, and limitations, etc.
Additionally, an all-inclusive account of the currently available Drug-Eluting Stents is provided, which will have an impact on the future market of Drug-Eluting Stents.
A detailed review of Drug-Eluting Stents market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
The report provides an edge while developing business strategies, by understanding trends shaping and driving the Drug-Eluting Stents market.

Report Highlights
The report covers descriptive overview of the Drug-Eluting Stents, explaining its applications, working mechanism, etc.
The report is a comprehensive account of marketed devices present in the Drug-Eluting Stents market.
The report also reviews the detailed historical and forecasted Drug-Eluting Stents market, including assessing the outreach in 7 MM.
The report helps in developing business strategies by understanding trends shaping and driving the Drug-Eluting Stents market.

Drug-Eluting Stents Report Key Strengths
6 Years Forecast
7MM Coverage
Competitive Landscape
PEST Analysis
Market Size

Drug-Eluting Stents Report Assessment
Marketed Product profiles
Key Products and Key Players
Market Drivers and Barriers
Market Forecast
KOL’S views

Key Questions
Market Insights:
What was the Drug-Eluting Stents market share (%) distribution in 2018 and how it will look like in 2026?
What will be the Drug-Eluting Stents total market size as well as market size by devices across the 7MM during the forecast period (2018–2026)?
What are the key findings pertaining to the market across the 7MM and which country will have the largest Drug-Eluting Stents market size during the forecast period (2018–2026)?
At what CAGR, the Drug-Eluting Stents market is expected to grow in the 7MM during the forecast period (2018–2026)?
What will be the Drug-Eluting Stents market outlook across the 7MM during the forecast period (2018–2026)?
What will be the Drug-Eluting Stents market growth till 2026 and what will be the resultant market size in the year 2026?
How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?

Competitive Landscape:
What are the current devices available in the Drug-Eluting Stents?
What is the Drug-Eluting Stents available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
How many key players are developing Drug-Eluting Stents?
What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Drug-Eluting Stents?
What are the key designations that have been granted for the current Drug-Eluting Stents?
What are the 7MM countries historical and forecasted market of Drug-Eluting Stents?

1. Key Insights
2. Executive Summary of Drug-Eluting Stents
3. Drug-Eluting Stents: Background and Overview
3.1. Introduction
3.2. Types of Drug-Eluting Stents
3.3. Advantages of Drug-Eluting Stents
3.4. Disadvantages of Drug-Eluting Stents
4. Drug-Eluting Stents: Regulatory Scenario
5. Drug-Eluting Stents: Reimbursement Scenario
6. Company Profiles
6.1. Abbott
6.1.1. Company Overview
6.1.2. Product Portfolio
6.1.2.1. Product description
6.1.2.2. Regulatory Milestones
6.1.2.3. Research and Development
6.1.2.4. Product Development Activities
6.2. B. Braun Melsungen AG
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.2.1. Product description
6.2.2.2. Regulatory Milestones
6.2.2.3. Research and Development
6.2.2.4. Product Development Activities
More Companies in the final report…
7. Drug-Eluting Stents: Competitive Analysis
8. KOL Views
9. Drug-Eluting Stents: Market Analysis in 7MM
9.1. Drug-Eluting Stents: Market Analysis in 7MM by Product type (2018–2026)
9.2. Drug-Eluting Stents: Market Analysis in 7MM by Scaffold (2018–2026)
9.3. Drug-Eluting Stents: Market Analysis in 7MM by End user (2018–2026)
10. Country-Wise Market size of Drug-Eluting Stents in 7MM (2018–2026)
10.1. Market size of Drug-Eluting Stents in the United States
10.1.1. Drug-Eluting Stents: Market Analysis in the United States by Product type (2018–2026)
10.1.2. Drug-Eluting Stents: Market Analysis in the United States by Scaffold (2018–2026)
10.1.3. Drug-Eluting Stents: Market Analysis in the United States by End user (2018–2026)
10.2. Market size of Drug-Eluting Stents in Germany
10.2.1. Drug-Eluting Stents: Market Analysis in Germany by Product type (2018–2026)
10.2.2. Drug-Eluting Stents: Market Analysis in Germany by Scaffold (2018–2026)
10.2.3. Drug-Eluting Stents: Market Analysis in Germany by End user (2018–2026)
10.3. Market size of Drug-Eluting Stents in France
10.3.1. Drug-Eluting Stents: Market Analysis in France by Product type (2018–2026)
10.3.2. Drug-Eluting Stents: Market Analysis in France by Scaffold (2018–2026)
10.3.3. Drug-Eluting Stents: Market Analysis in France by End user (2018–2026)
10.4. Market size of Drug-Eluting Stents in Spain
10.4.1. Drug-Eluting Stents: Market Analysis in Spain by Product type (2018–2026)
10.4.2. Drug-Eluting Stents: Market Analysis in Spain by Scaffold (2018–2026)
10.4.3. Drug-Eluting Stents: Market Analysis in Spain by End user (2018–2026)
10.5. Market size of Drug-Eluting Stents in Italy
10.5.1. Drug-Eluting Stents: Market Analysis in Italy by Product type (2018–2026)
10.5.2. Drug-Eluting Stents: Market Analysis in Italy by Scaffold (2018–2026)
10.5.3. Drug-Eluting Stents: Market Analysis in Italy by End user (2018–2026)
10.6. Market size of Drug-Eluting Stents in the UK
10.6.1. Drug-Eluting Stents: Market Analysis in the UK by Product type (2018–2026)
10.6.2. Drug-Eluting Stents: Market Analysis in the UK by Scaffold (2018–2026)
10.6.3. Drug-Eluting Stents: Market Analysis in the UK by End user (2018–2026)
10.7. Market size of Drug-Eluting Stents in Japan
10.7.1. Drug-Eluting Stents: Market Analysis in Japan by Product type (2018–2026)
10.7.2. Drug-Eluting Stents: Market Analysis in Japan by Scaffold (2018–2026)
10.7.3. Drug-Eluting Stents: Market Analysis in Japan by End user (2018–2026)
11. Market Dynamic
11.1. Market Drivers
11.2. Market Barriers
12. PEST Analysis
13. Conclusion and Future Perspective
14. Appendix
14.1. Bibliography
14.2. Report Methodology
15. DelveInsight Capabilities
16. Disclaimer
17. About DelveInsight

Table 1: Competitive Analysis
Table 2: Drug-Eluting Stents: Market Analysis in the 7MM (2018–2026)
Table 3: Drug-Eluting Stents: Market Analysis in the 7MM by Product type (2018–2026)
Table 4: Drug-Eluting Stents: Market Analysis in the 7MM by Scaffold (2018–2026)
Table 5: Drug-Eluting Stents: Market Analysis in the 7MM by End user (2018–2026)
Table 6: Drug-Eluting Stents: United States Market Analysis (2018–2026)
Table 7: Drug-Eluting Stents: Market Analysis in the US by Product type (2018-2026)
Table 8: Drug-Eluting Stents: Market Analysis in the US by Scaffold (2018-2026)
Table 9: Drug-Eluting Stents: Market Analysis in the US by End user (2018-2026)
Table 10: Drug-Eluting Stents: Germany Market Analysis (2018–2026)
Table 11: Drug-Eluting Stents: Market Analysis in Germany by Product type (2018-2026)
Table 12: Drug-Eluting Stents: Market Analysis in Germany by Scaffold (2018-2026)
Table 13: Drug-Eluting Stents: Market Analysis in Germany by End user (2018-2026)
Table 14: Drug-Eluting Stents: France Market Analysis (2018–2026)
Table 15: Drug-Eluting Stents: Market Analysis in France by Product type (2018-2026)
Table 16: Drug-Eluting Stents: Market Analysis in France by Scaffold (2018-2026)
Table 17: Drug-Eluting Stents: Market Analysis in France by End user (2018-2026)
Table 18: Drug-Eluting Stents: Spain Market Analysis (2018–2026)
Table 19: Drug-Eluting Stents: Market Analysis in Spain by Product type (2018-2026)
Table 20: Drug-Eluting Stents: Market Analysis in Spain by Scaffold (2018-2026)
Table 21: Drug-Eluting Stents: Market Analysis in Spain by End user (2018-2026)
Table 22: Drug-Eluting Stents: Italy Market Analysis (2018–2026)
Table 23: Drug-Eluting Stents: Market Analysis in Italy by Product type (2018-2026)
Table 24: Drug-Eluting Stents: Market Analysis in Italy by Scaffold (2018-2026)
Table 25: Drug-Eluting Stents: Market Analysis in Italy by End user (2018-2026)
Table 26: Drug-Eluting Stents: United Kingdom Market Analysis (2018–2026)
Table 27: Drug-Eluting Stents: Market Analysis in the UK by Product type (2018-2026)
Table 28: Drug-Eluting Stents: Market Analysis in the UK by Scaffold (2018-2026)
Table 29: Drug-Eluting Stents: Market Analysis in the UK by End user (2018-2026)
Table 30: Drug-Eluting Stents: Japan Market Analysis (2018–2026)
Table 31: Drug-Eluting Stents: Market Analysis in Japan by Product type (2018-2026)
Table 32: Drug-Eluting Stents: Market Analysis in Japan by Scaffold (2018-2026)
Table 33: Drug-Eluting Stents: Market Analysis in Japan by End user (2018-2026)
Figure 1: Product description of Drug-Eluting Stents
Figure 2: Drug-Eluting Stents: Market Analysis in the 7MM (2018–2026)
Figure 3: Drug-Eluting Stents: Market Analysis in the 7MM by Product type (2018–2026)
Figure 4: Drug-Eluting Stents: Market Analysis in the 7MM by Scaffold (2018–2026)
Figure 5: Drug-Eluting Stents: Market Analysis in the 7MM by End user (2018–2026)
Figure 6: Drug-Eluting Stents: United States Market Analysis (2018–2026)
Figure 7: Drug-Eluting Stents: Market Analysis in the US by Product type (2018-2026)
Figure 8: Drug-Eluting Stents: Market Analysis in the US by Scaffold (2018-2026)
Figure 9: Drug-Eluting Stents: Market Analysis in the US by End user (2018-2026)
Figure 10: Drug-Eluting Stents: Germany Market Analysis (2018–2026)
Figure 11: Drug-Eluting Stents: Market Analysis in Germany by Product type (2018-2026)
Figure 12: Drug-Eluting Stents: Market Analysis in Germany by Scaffold (2018-2026)
Figure 13: Drug-Eluting Stents: Market Analysis in Germany by End user (2018-2026)
Figure 14: Drug-Eluting Stents: France Market Analysis (2018–2026)
Figure 15: Drug-Eluting Stents: Market Analysis in France by Product type (2018-2026)
Figure 16: Drug-Eluting Stents: Market Analysis in France by Scaffold (2018-2026)
Figure 17: Drug-Eluting Stents: Market Analysis in France by End user (2018-2026)
Figure 18: Drug-Eluting Stents: Spain Market Analysis (2018–2026)
Figure 19: Drug-Eluting Stents: Market Analysis in Spain by Product type (2018-2026)
Figure 20: Drug-Eluting Stents: Market Analysis in Spain by Scaffold (2018-2026)
Figure 21: Drug-Eluting Stents: Market Analysis in Spain by End user (2018-2026)
Figure 22: Drug-Eluting Stents: Italy Market Analysis (2018–2026)
Figure 23: Drug-Eluting Stents: Market Analysis in Italy by Product type (2018-2026)
Figure 24: Drug-Eluting Stents: Market Analysis in Italy by Scaffold (2018-2026)
Figure 25: Drug-Eluting Stents: Market Analysis in Italy by End user (2018-2026)
Figure 26: Drug-Eluting Stents: United Kingdom Market Analysis (2018–2026)
Figure 27: Drug-Eluting Stents: Market Analysis in the UK by Product type (2018-2026)
Figure 28: Drug-Eluting Stents: Market Analysis in the UK by Scaffold (2018-2026)
Figure 29: Drug-Eluting Stents: Market Analysis in the UK by End user (2018-2026)
Figure 30: Drug-Eluting Stents: Japan Market Analysis (2018–2026)
Figure 31: Drug-Eluting Stents: Market Analysis in Japan by Product type (2018-2026)
Figure 32: Drug-Eluting Stents: Market Analysis in Japan by Scaffold (2018-2026)
Figure 33: Drug-Eluting Stents: Market Analysis in Japan by End user (2018-2026)
Figure 34: Market Drivers
Figure 35: Market Barriers